Company news
Ion Beam Applications Sa (EURONEXT:IBAB) news
Every Ion Beam Applications Sa press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications
September 2, 2026
IBA reports Half Year 2026 results, on track with its improved profitability trajectory
August 27, 2026
IBA Notice of Half Year 2026 Results and Conference Call
August 6, 2026
IBA to install the first proton therapy center in Brazil in Rio de Janeiro
June 25, 2026
IBA strengthens its Board with two high-profile appointments and announces the payment date of its dividend
June 17, 2026
IBA strengthens its leadership team to support its growth
June 17, 2026
IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy
June 10, 2026
IBA signs contract with a major U.S. academic medical center to install two Proteus®ONE proton therapy solutions
June 8, 2026
IBA launches Cyclone® iKure, a cyclotron designed for industrial scale Astatine-211 production
June 1, 2026
First quarter 2026 update: starting the year on track, with product innovation progress
May 21, 2026
IBA launches Rhodotron® LITE, a new low‑power X‑ray accelerator expanding access to sustainable irradiation solutions
May 20, 2026
IBA introduces AdaPTinsight XR, the next generation of CBCT imaging for image-guided proton therapy
May 13, 2026
IBA Introduces myQA StarTrack³ for Fast, High Resolution Linac QA with a Single Detector Setup
May 6, 2026
IBA – ACQUISITION OF OWN SHARES
April 27, 2026
IBA delivers strong FY 2025 results with solid execution in all segments
March 27, 2026
IBA Launches myQAMatriXXAiR to Advance Patient‑Specific QA in Particle Therapy
March 21, 2026
Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.
March 20, 2026
IBA Notice of Full Year 2025 Results and Conference Call
March 13, 2026
IBA – TRANSPARENCY NOTIFICATION
February 25, 2026
IBA and Shreeji sign multi‑site agreement for four cyclotrons to expand PET radiopharmaceutical manufacturing across India
February 19, 2026
IBA – Share buyback
February 2, 2026
IBA signs contract for a Proteus®ONE proton therapy system to be located at the MacKay Memorial Hospital in New Taipei City, Taiwan
January 27, 2026
IBA selected by MD Anderson Cancer Center to supply three Proteus®ONE systems
January 19, 2026
IBA signs contract for a three-room Proteus®PLUS solution to be installed at the Seoul St. Mary’s Hospital
December 26, 2025
IBA acquires ORA expanding its strategic leadership in Nuclear Medicine
December 19, 2025
Proton Therapy New Standard of Care for Patients with Oropharyngeal Cancer
December 15, 2025
China Gold Irradiation Introduces IBA’s sustainable X-ray irradiation technology to expand its production capacity
December 11, 2025
YAS Healthcare signs contract for a Proteus®ONE solution, the first proton therapy system to be installed in Dubai, UAE
December 8, 2025
Third quarter 2025 update: IBA is highly confident to meet FY2025 guidance, and strengthens financing structure
November 20, 2025
IBA – Regulated information
November 7, 2025
IBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbH
November 3, 2025
IBA opens the world of science and technology to secondary school girls
October 17, 2025
IBA reports strong Half Year 2025 results, transforming towards a more profitable business
August 28, 2025
Heidelberg University Hospital expands its particle therapy program with IBA’s Proteus®ONE solution
August 20, 2025
IBA Notice of Half Year 2025 Results and Conference Call
August 7, 2025
IBA – Transparency Notification - Denominator
June 30, 2025
Steri-Tek to boost sterilization capacity of its Texas-based center fivefold with IBA’s X-ray irradiation system
June 18, 2025
World's Leading Institutions and IBA launch Proton Therapy Academy to shape the future of cancer care
June 4, 2025
Iba – Acquisition of Own Shares - Completion of the Share Buyback Program
May 30, 2025
IBA Business Update Q1 2025
May 22, 2025
IBA and PET Pharm Bio sign contract to install a Cyclone® IKON in Taiwan
May 21, 2025
IBA launches CASSY®, a new compact radiochemistry module to enhance efficiency in radiopharmaceuticals production
May 13, 2025
CONVENING NOTICE TO THE ORDINARY GENERAL MEETING 2025 OF IBA SA
May 12, 2025
IBA launches QUASAR® GRID3D Advantage Image Distortion Analysis System
May 3, 2025
IBA launches myQA Blue Phantom³ for radiation therapy quality assurance
May 2, 2025